The (WMS) is preparing for its annual Targeting Mitochondria 2024 conference, which will focus on innovative strategies to "charge" cells by supplying them with extra mitochondria to enhance cellular ...

There have been significant advances made over the past decade in the treatment of blood cancer; it has led to improved outcomes and survival rates, says a doctor. Blood cancers or hematologic ...

Treatment for blood cancers is advancing, giving more options to people living with the disease. Sikander Ailawadhi, M.D., an oncologist and hematologist at Mayo Clinic in Jacksonville ...

Blood cancers, including leukaemia, lymphoma, and myeloma, relate to malfunction in the production and functioning of blood cells. Blood cancers are no longer a rare condition as the cases are ...

Blood tests for cancer detection, known as liquid biopsies, can still be unreliable, but progress is being made. Competition between different diagnostics companies is also intensifying.

Each year, more than 1 400 South African children are diagnosed with blood cancer, which accounts for 33% of all childhood cancers in the country. Although it is treatable and potentially curable ...

Blood cancer isn't just one disease—it's an umbrella term that covers several types. Leukemia, often thought of as a childhood cancer, can affect people of all ages. •Lymphoma, which invades ...

Over the weekend, during the lead-up to Exact Sciences announcing data from a blood-based colon cancer test, Guardant Health co-CEO AmirAli Talasaz challenged Exact’s CEO, Kevin Conroy ...

Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election Research from Blood Cancer UK, shared exclusively with ...

Novartis’ blood cancer sculpture tour has reached a new destination. The Swiss drugmaker, which put the sculptures on show in London one year ago, is marking this year’s Blood Cancer Awareness ...

The researchers analyzed blood samples from the participants to measure levels of IL-6, TNF-alpha, and hsCRP, in an effort to understand their relationship with the development of OR cancers.

ABOUT 35% IS USED IN SURGERY, AND THE HIGHEST AMOUNT, 38%, IS USED TO TREAT PATIENTS WITH CANCER AND BLOOD DISORDERS. BRUNEL ETIENNE IS ONE OF THEM. I SICKLE CELL ANEMIA. ETIENNE INHERITED THIS ...